NRXP
Price:
$1.57
Market Cap:
$18.99M
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.[Read more]
Industry
Biotechnology
IPO Date
2017-12-04
Stock Exchange
NASDAQ
Ticker
NRXP
According to NRx Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.20. This represents a change of -14.60% compared to the average of 0.24 of the last 4 quarters.
The mean historical Current Ratio of NRx Pharmaceuticals, Inc. over the last ten years is 1.52. The current 0.20 Current Ratio has changed 1.23% with respect to the historical average. Over the past ten years (40 quarters), NRXP's Current Ratio was at its highest in in the December 2017 quarter at 5.76. The Current Ratio was at its lowest in in the March 2020 quarter at 0.00.
Average
1.52
Median
0.36
Minimum
0.05
Maximum
5.76
Discovering the peaks and valleys of NRx Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.22%
Maximum Annual Current Ratio = 5.76
Minimum Annual Increase = -99.08%
Minimum Annual Current Ratio = 0.05
Year | Current Ratio | Change |
---|---|---|
2023 | 0.36 | -76.76% |
2022 | 1.56 | -43.31% |
2021 | 2.74 | 4.22% |
2020 | 0.06 | -43.15% |
2019 | 0.11 | 109.80% |
2018 | 0.05 | -99.08% |
The current Current Ratio of NRx Pharmaceuticals, Inc. (NRXP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.55
5-year avg
0.97
10-year avg
1.52
NRx Pharmaceuticals, Inc.’s Current Ratio is less than BiomX Inc. (0), less than Lexaria Bioscience Corp. (3.17), less than Aditxt, Inc. (7.18), greater than Nutriband Inc. (0.09), less than Quoin Pharmaceuticals, Ltd. (0), less than Longeveron Inc. (4.96), less than RenovoRx, Inc. (3.02), less than Virax Biolabs Group Limited (7.67), less than SAB Biotherapeutics, Inc. (5.66), less than Senti Biosciences, Inc. (25.94), less than Cingulate Inc. (3.69), less than Bellicum Pharmaceuticals, Inc. (1.92), less than Hillstream BioPharma, Inc. (7.35), less than null (3.04), less than null (2.25),
Company | Current Ratio | Market cap |
---|---|---|
0 | $9.88M | |
3.17 | $38.57M | |
7.18 | $2.62M | |
0.09 | $43.21M | |
0 | $2.45M | |
4.96 | $26.11M | |
3.02 | $30.96M | |
7.67 | $7.47M | |
5.66 | $461.46K | |
25.94 | $19.13M | |
3.69 | $15.61M | |
1.92 | $778.33K | |
7.35 | $4.17M | |
3.04 | $0 | |
2.25 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NRx Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NRx Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is NRx Pharmaceuticals, Inc.'s Current Ratio?
How is the Current Ratio calculated for NRx Pharmaceuticals, Inc. (NRXP)?
What is the highest Current Ratio for NRx Pharmaceuticals, Inc. (NRXP)?
What is the 3-year average Current Ratio for NRx Pharmaceuticals, Inc. (NRXP)?
What is the 5-year average Current Ratio for NRx Pharmaceuticals, Inc. (NRXP)?
How does the current Current Ratio for NRx Pharmaceuticals, Inc. (NRXP) compare to its historical average?